Quilizumab

Quilizumab (INN) is a humanized monoclonal antibody designed for the treatment of asthma.^[1] It binds to IGHE.^{[2][3][4][5][6][7]}

Quilizumab

Monoclonal antibody
Type	Whole antibody
Source	Humanized (from mouse)
Target	IGHE
Clinical data
ATC code	none
Identifiers
CAS Number	1228538-47-3
ChemSpider	none
UNII	26F96HRJ3W
KEGG	D10409
Chemical and physical data
Formula	C6492H10046N1728O2023S44
Molar mass	146082.49 g·mol−1

This drug was developed by Genentech.